ID   TCP4_HUMAN              Reviewed;         127 AA.
AC   P53999; Q96L29;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-APR-2021, entry version 188.
DE   RecName: Full=Activated RNA polymerase II transcriptional coactivator p15;
DE   AltName: Full=Positive cofactor 4;
DE            Short=PC4;
DE   AltName: Full=SUB1 homolog;
DE   AltName: Full=p14;
GN   Name=SUB1; Synonyms=PC4, RPO2TC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND FUNCTION.
RX   PubMed=8062392; DOI=10.1016/0092-8674(94)90429-4;
RA   Kretzschmar M., Kaiser K., Lottspeich F., Meisterernst M.;
RT   "A novel mediator of class II gene transcription with homology to viral
RT   immediate-early transcriptional regulators.";
RL   Cell 78:525-534(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 2-11 AND 81-97, AND
RP   FUNCTION.
RX   PubMed=8062391; DOI=10.1016/0092-8674(94)90428-6;
RA   Ge H., Roeder R.G.;
RT   "Purification, cloning, and characterization of a human coactivator, PC4,
RT   that mediates transcriptional activation of class II genes.";
RL   Cell 78:513-523(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-11.
RC   TISSUE=Bone marrow, Cervix, Lung, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION, AND MASS SPECTROMETRY.
RX   PubMed=7809103; DOI=10.1073/pnas.91.26.12691;
RA   Ge H., Zhao Y., Chait B.T., Roeder R.G.;
RT   "Phosphorylation negatively regulates the function of coactivator PC4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12691-12695(1994).
RN   [5]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=7628453; DOI=10.1002/j.1460-2075.1995.tb07358.x;
RA   Kaiser K., Stelzer G., Meisterernst M.;
RT   "The coactivator p15 (PC4) initiates transcriptional activation during
RT   TFIIA-TFIID-promoter complex formation.";
RL   EMBO J. 14:3520-3527(1995).
RN   [6]
RP   FUNCTION, AND PHOSPHORYLATION BY CK2.
RX   PubMed=9482861; DOI=10.1073/pnas.95.5.2192;
RA   Malik S., Guermah M., Roeder R.G.;
RT   "A dynamic model for PC4 coactivator function in RNA polymerase II
RT   transcription.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2192-2197(1998).
RN   [7]
RP   INTERACTION WITH CSTF2.
RX   PubMed=11389848; DOI=10.1016/s1097-2765(01)00236-2;
RA   Calvo O., Manley J.L.;
RT   "Evolutionarily conserved interaction between CstF-64 and PC4 links
RT   transcription, polyadenylation, and termination.";
RL   Mol. Cell 7:1013-1023(2001).
RN   [8]
RP   MASS SPECTROMETRY, FUNCTION, DNA-BINDING, AND PHOSPHORYLATION AT SER-11;
RP   SER-13; SER-15; SER-17 AND SER-19.
RX   PubMed=16689930; DOI=10.1111/j.1742-4658.2006.05165.x;
RA   Jonker H.R.A., Wechselberger R.W., Pinkse M., Kaptein R., Folkers G.E.;
RT   "Gradual phosphorylation regulates PC4 coactivator function.";
RL   FEBS J. 273:1430-1444(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-35 AND LYS-68, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-19; SER-55; SER-56;
RP   SER-57; SER-58 AND SER-118, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-9; SER-10; SER-13;
RP   SER-15; SER-17; SER-19 AND SER-118, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-68, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-68, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 63-127, FUNCTION, AND SUBUNIT.
RX   PubMed=9360603; DOI=10.1038/nsb1197-900;
RA   Brandsen J., Werten S., van der Vliet P.C., Meisterernst M., Kroon J.,
RA   Gros P.;
RT   "C-terminal domain of transcription cofactor PC4 reveals dimeric ssDNA
RT   binding site.";
RL   Nat. Struct. Biol. 4:900-903(1997).
RN   [22]
RP   STRUCTURE BY NMR, FUNCTION, AND MUTAGENESIS OF LYS-68; ARG-75;
RP   77-PHE--LYS-80; ARG-86 AND LYS-101.
RX   PubMed=16605275; DOI=10.1021/bi052531b;
RA   Jonker H.R.A., Wechselberger R.W., Boelens R., Kaptein R., Folkers G.E.;
RT   "The intrinsically unstructured domain of PC4 modulates the activity of the
RT   structured core through inter- and intramolecular interactions.";
RL   Biochemistry 45:5067-5081(2006).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 63-127 IN COMPLEX WITH
RP   SINGLE-STRANDED DNA, AND SUBUNIT.
RX   PubMed=16415882; DOI=10.1038/nsmb1044;
RA   Werten S., Moras D.;
RT   "A global transcription cofactor bound to juxtaposed strands of unwound
RT   DNA.";
RL   Nat. Struct. Biol. 13:181-182(2006).
CC   -!- FUNCTION: General coactivator that functions cooperatively with TAFs
CC       and mediates functional interactions between upstream activators and
CC       the general transcriptional machinery. May be involved in stabilizing
CC       the multiprotein transcription complex. Binds single-stranded DNA. Also
CC       binds, in vitro, non-specifically to double-stranded DNA (ds DNA).
CC       {ECO:0000269|PubMed:16605275, ECO:0000269|PubMed:16689930,
CC       ECO:0000269|PubMed:7628453, ECO:0000269|PubMed:8062391,
CC       ECO:0000269|PubMed:8062392, ECO:0000269|PubMed:9360603,
CC       ECO:0000269|PubMed:9482861}.
CC   -!- SUBUNIT: Homodimer. Interacts with CSTF2. {ECO:0000269|PubMed:11389848,
CC       ECO:0000269|PubMed:16415882, ECO:0000269|PubMed:9360603}.
CC   -!- INTERACTION:
CC       P53999; P28288-2: ABCD3; NbExp=3; IntAct=EBI-998260, EBI-25889034;
CC       P53999; P33240-1: CSTF2; NbExp=3; IntAct=EBI-998260, EBI-711374;
CC       P53999; Q6P4D5-2: FAM122C; NbExp=3; IntAct=EBI-998260, EBI-9091052;
CC       P53999; O00560: SDCBP; NbExp=3; IntAct=EBI-998260, EBI-727004;
CC       P53999; P53999: SUB1; NbExp=5; IntAct=EBI-998260, EBI-998260;
CC       P53999; P03132: Rep68; Xeno; NbExp=3; IntAct=EBI-998260, EBI-7387242;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Activity is controlled by protein kinases that target the
CC       regulatory region. Phosphorylation inactivates both ds DNA-binding and
CC       cofactor function, but does not affect binding to ssDNA. Seems to be
CC       phosphorylated in vivo by CK2 in at least 7 sites in the N-terminal
CC       Ser-rich region. {ECO:0000269|PubMed:16689930,
CC       ECO:0000269|PubMed:7809103, ECO:0000269|PubMed:9482861}.
CC   -!- MASS SPECTROMETRY: Mass=14266; Mass_error=4; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:7809103};
CC   -!- MASS SPECTROMETRY: Mass=14263; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:16689930};
CC   -!- SIMILARITY: Belongs to the transcriptional coactivator PC4 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X79805; CAA56200.1; -; mRNA.
DR   EMBL; U12979; AAA20980.1; -; mRNA.
DR   EMBL; BC009610; AAH09610.1; -; mRNA.
DR   EMBL; BC010537; AAH10537.1; -; mRNA.
DR   EMBL; BC018189; AAH18189.1; -; mRNA.
DR   EMBL; BC022339; AAH22339.1; -; mRNA.
DR   CCDS; CCDS3897.1; -.
DR   PIR; A54670; A54670.
DR   RefSeq; NP_006704.3; NM_006713.3.
DR   RefSeq; XP_011512246.1; XM_011513944.2.
DR   RefSeq; XP_016864475.1; XM_017008986.1.
DR   RefSeq; XP_016864476.1; XM_017008987.1.
DR   PDB; 1PCF; X-ray; 1.74 A; A/B/C/D/E/F/G/H=63-127.
DR   PDB; 2C62; X-ray; 1.74 A; A/B=63-127.
DR   PDB; 2PHE; NMR; -; A/B=63-127.
DR   PDB; 4USG; X-ray; 1.97 A; A/B=63-127.
DR   PDB; 6YCS; X-ray; 3.05 A; A/B/C/D=61-127.
DR   PDBsum; 1PCF; -.
DR   PDBsum; 2C62; -.
DR   PDBsum; 2PHE; -.
DR   PDBsum; 4USG; -.
DR   PDBsum; 6YCS; -.
DR   BMRB; P53999; -.
DR   SMR; P53999; -.
DR   BioGRID; 116127; 113.
DR   CORUM; P53999; -.
DR   DIP; DIP-29044N; -.
DR   IntAct; P53999; 30.
DR   MINT; P53999; -.
DR   STRING; 9606.ENSP00000265073; -.
DR   iPTMnet; P53999; -.
DR   MetOSite; P53999; -.
DR   PhosphoSitePlus; P53999; -.
DR   SwissPalm; P53999; -.
DR   BioMuta; SUB1; -.
DR   DMDM; 1709514; -.
DR   EPD; P53999; -.
DR   jPOST; P53999; -.
DR   MassIVE; P53999; -.
DR   PaxDb; P53999; -.
DR   PeptideAtlas; P53999; -.
DR   PRIDE; P53999; -.
DR   ProteomicsDB; 56641; -.
DR   TopDownProteomics; P53999; -.
DR   Antibodypedia; 681; 259 antibodies.
DR   Ensembl; ENST00000265073; ENSP00000265073; ENSG00000113387.
DR   Ensembl; ENST00000502897; ENSP00000427100; ENSG00000113387.
DR   Ensembl; ENST00000506237; ENSP00000422078; ENSG00000113387.
DR   Ensembl; ENST00000512913; ENSP00000422806; ENSG00000113387.
DR   Ensembl; ENST00000515355; ENSP00000426850; ENSG00000113387.
DR   GeneID; 10923; -.
DR   KEGG; hsa:10923; -.
DR   CTD; 10923; -.
DR   DisGeNET; 10923; -.
DR   GeneCards; SUB1; -.
DR   HGNC; HGNC:19985; SUB1.
DR   HPA; ENSG00000113387; Low tissue specificity.
DR   MIM; 600503; gene.
DR   neXtProt; NX_P53999; -.
DR   OpenTargets; ENSG00000113387; -.
DR   PharmGKB; PA142670858; -.
DR   VEuPathDB; HostDB:ENSG00000113387.11; -.
DR   eggNOG; KOG2712; Eukaryota.
DR   GeneTree; ENSGT00390000008802; -.
DR   HOGENOM; CLU_104273_1_1_1; -.
DR   InParanoid; P53999; -.
DR   OMA; REYYQDK; -.
DR   OrthoDB; 1525616at2759; -.
DR   PhylomeDB; P53999; -.
DR   TreeFam; TF313859; -.
DR   PathwayCommons; P53999; -.
DR   SIGNOR; P53999; -.
DR   BioGRID-ORCS; 10923; 52 hits in 975 CRISPR screens.
DR   ChiTaRS; SUB1; human.
DR   EvolutionaryTrace; P53999; -.
DR   GeneWiki; SUB1; -.
DR   GenomeRNAi; 10923; -.
DR   Pharos; P53999; Tbio.
DR   PRO; PR:P53999; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P53999; protein.
DR   Bgee; ENSG00000113387; Expressed in epithelium of mammary gland and 251 other tissues.
DR   ExpressionAtlas; P53999; baseline and differential.
DR   Genevisible; P53999; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0051053; P:negative regulation of DNA metabolic process; IDA:CACAO.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl.
DR   DisProt; DP01804; -.
DR   Gene3D; 2.30.31.10; -; 1.
DR   IDEAL; IID00306; -.
DR   InterPro; IPR003173; PC4.
DR   InterPro; IPR009044; ssDNA-bd_transcriptional_reg.
DR   Pfam; PF02229; PC4; 1.
DR   SUPFAM; SSF54447; SSF54447; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Direct protein sequencing;
KW   DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:8062391"
FT   CHAIN           2..127
FT                   /note="Activated RNA polymerase II transcriptional
FT                   coactivator p15"
FT                   /id="PRO_0000215944"
FT   REGION          2..50
FT                   /note="Regulatory"
FT   REGION          77..101
FT                   /note="Interaction with ssDNA"
FT   COMPBIAS        4..19
FT                   /note="Ser-rich"
FT   COMPBIAS        23..53
FT                   /note="Lys-rich"
FT   COMPBIAS        50..58
FT                   /note="Ser-rich"
FT   SITE            50..51
FT                   /note="Cleavage"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16689930"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16689930,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16689930,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16689930,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16689930,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         35
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         53
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11031"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         68
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   CROSSLNK        68
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        68
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         11
FT                   /note="S -> G (in dbSNP:rs17850527)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032870"
FT   MUTAGEN         68
FT                   /note="K->G: Reduced ssDNA binding."
FT                   /evidence="ECO:0000269|PubMed:16605275"
FT   MUTAGEN         75
FT                   /note="R->G: Reduced ssDNA binding."
FT                   /evidence="ECO:0000269|PubMed:16605275"
FT   MUTAGEN         77..80
FT                   /note="FKGK->AGG: Loss of ssDNA binding."
FT                   /evidence="ECO:0000269|PubMed:16605275"
FT   MUTAGEN         86
FT                   /note="R->G: Loss of ssDNA binding."
FT                   /evidence="ECO:0000269|PubMed:16605275"
FT   MUTAGEN         101
FT                   /note="K->G: Loss of ssDNA binding."
FT                   /evidence="ECO:0000269|PubMed:16605275"
FT   STRAND          63..67
FT                   /evidence="ECO:0007744|PDB:1PCF"
FT   STRAND          70..77
FT                   /evidence="ECO:0007744|PDB:1PCF"
FT   STRAND          80..90
FT                   /evidence="ECO:0007744|PDB:1PCF"
FT   STRAND          92..94
FT                   /evidence="ECO:0007744|PDB:2PHE"
FT   STRAND          96..105
FT                   /evidence="ECO:0007744|PDB:1PCF"
FT   HELIX           107..126
FT                   /evidence="ECO:0007744|PDB:1PCF"
SQ   SEQUENCE   127 AA;  14395 MW;  0DAE0CAAAD5E4E15 CRC64;
     MPKSKELVSS SSSGSDSDSE VDKKLKRKKQ VAPEKPVKKQ KTGETSRALS SSKQSSSSRD
     DNMFQIGKMR YVSVRDFKGK VLIDIREYWM DPEGEMKPGR KGISLNPEQW SQLKEQISDI
     DDAVRKL
//
